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Questions to be addressed by ACIP
 Should the current recommendation that non-pregnant adults receive a 
single lifetime dose of Tdap with Td boosters every 10 years be changed to 
allow any Td-containing vaccine (Tdap or Td) to be used for the decennial 
Td booster? 
 Should any Td-containing vaccine (Tdap or Td) be allowed for tetanus 
prophylaxis in the setting of wound management?
 New: Should the catch-up immunization schedule for Tdap/Td be changed 
for those ≥7 years of age? 
What prompted these questions?
 FDA label change to Sanofi’s Tdap product (Adacel) 
– Routine booster: Allows a second dose of Adacel may be administered 
≥8 years after the first dose of Tdap 
– Wound management: A booster dose of Adacel may be administered if 
≥5 years since previous receipt of a tetanus toxoid containing vaccine
 No change to GSK’s Tdap product (Boostrix) 
 Evidence that repeat Tdap vaccination is widespread
Current ACIP Tdap recommendations: 
Non-pregnant adolescents and adults
 Single Tdap dose
– Adolescents 11–18 years, preferred 11–12 years (2005)
– Adults ≥19 years (2005)
• No minimum interval since last Td vaccine
 Previously received Tdap: 
– Decennial Td booster 
– Use Td for wound management 
• If Td unavailable, may administer Tdap
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Tdap primary immunization for ≥7 years of age for 
those not fully immunized
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Current 
recommendations
Tdap
 1 dose Tdap as part of the catch-up series (preferably the first dose)
 If additional doses are needed, use Td
 Catch-up schedule includes pregnant women
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